Sand Hill Angels — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
AltrixBio develops AJN003, a once-daily oral therapy that forms a temporary, non-systemic coating on the stomach and upper gastrointestinal tract to alter nutrient sensing and trigger metabolic and hormonal responses.
BiotechDigital HealthHealthtechLongevityWilmington, US
Ali Tavakkoli(Co-founder)Nancy Briefs(Executive Chair of the Board & Founder)inJeff Karp(Co-founder)David Passin
BoardJohn Brooks(Director)
Co-investorsService Provider CapitalTaihill VentureWalnut Venture Associatesxfactor ventures
Revel Ai provides AI-powered infrastructure for hospitals to manage episode-based care coordination and regulatory compliance under CMS's Transforming Episode Accountability Model.
AI & Machine LearningDigital HealthHealthtechSaaSWoodbridge, US
Christian Péan(CEO & Co-Founder)inHadi Javeed(CTO & Co-Founder)in
BoardClint Korver(Director)in
Co-investorsSymphonic CapitalTechstarsTriangle TweenerUlu Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.










